Rewriting the Rules: Gene Therapy and Clinical Trials in Pregnancy

Thursday, January 28, 2027 at 12:30 PM to 1:00 PM · 30 min. (Europe/London)
Women & Children's Health Stage
Day 2 - Thursday 28th January
Women & Children's Health

Information

  • Why pregnant women have historically been excluded from clinical trials, and the consequences this has had had for not only pregnancy-specific conditions such as preeclampsia and fetal growth restriction, but also women of reproductive age on medication who conceive. 
  • How new safety frameworks, regulatory developments and trial designs are making it possible to conduct research in pregnancy safely and responsibly for both mother and baby. 
  • The opportunities presented by emerging fetal therapies, including gene therapies and other interventions that could enable treatment before birth. 
  • How genomics, improved phenotyping and technologies such as single-cell and spatial biology are providing the biological understanding needed to develop the next generation of precision therapies in pregnancy.